Bioceres Crop Solutions Corp. (BIOX) stock
BIOXNasdaqAgricultural ChemicalsFiscal year ends June 30
$0.22−0.01 (-4.60%)
Close on Nov 12, 2026Market cap $14.17MP/E –Yield –
Bioceres Crop Solutions total assets
Total assets on the balance sheet at the end of each period.
Bioceres Crop Solutions's total assets was $448.23M at Jun 30, 2026. For fiscal 2026 it was $448.23M, down 41.3% from the year before. The highest annual figure on record is $852.55M in fiscal 2024.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $448.23M | -41.3% |
| FY2025 | Jun 30, 2025 | $763.65M | -10.4% |
| FY2024 | Jun 30, 2024 | $852.55M | +4.2% |
| FY2023 | Jun 30, 2023 | $818.06M | +57.9% |
| FY2022 | Jun 30, 2022 | $518.22M | +31.3% |
| FY2021 | Jun 30, 2021 | $394.59M | +32.6% |
| FY2020 | Jun 30, 2020 | $297.56M | +22.7% |
| FY2019 | Jun 30, 2019 | $242.47M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $448.23M | -43.8% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $560.36M | -32.9% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $734.88M | -11.2% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $763.65M | -10.4% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $798.21M | -4.5% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $835.20M | +1.9% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $827.26M | +0.9% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $852.55M | +4.2% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $836.13M | -1.3% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $819.52M | -6.1% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $819.70M | +58.2% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $818.06M | +74.2% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $846.80M | +114.6% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $872.85M | +152.5% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $518.22M | +74.2% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $469.64M | +79.5% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $394.59M | +62.7% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $345.73M | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $297.56M | – |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $261.58M | – |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $242.47M | – |
See a number that looks wrong?